Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anja Schmitt

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Blood Advances|June 25, 2026
Three generations, one target: BTK inhibitors in lymphomaAnja Schmitt, Stephan Hailfinger
Proceedings of the National Academy of Sciences of the United States of America|March 21, 2002
Inhibition of Xenopus oocyte meiotic maturation by catalytically inactive protein kinase AAnja Schmitt, Angel R Nebreda
Journal of Cell Science|June 5, 2002
Signalling pathways in oocyte meiotic maturationAnja Schmitt, Angel R Nebreda
Frontiers of Hormone Research|August 26, 2015
Pathology: Classification and ImmunoprofileAnnika Blank, Anja Schmitt, Aurel Perren
The FEBS Journal|December 31, 2015
The paracaspase MALT1 dampens NF-κB signalling by cleaving the LUBAC subunit HOIL-1Stephan Hailfinger, Anja Schmitt, Klaus Schulze-Osthoff
Therapeutische Umschau. Revue Therapeutique|October 2, 2010
[Pathology of malignant lymphomas--clarity instead of confusion]Esther Mueller-Garamvölgyi, Aurel Perren, Anja Schmitt
Cell Death and Differentiation|January 21, 2018
Correspondence: T cells are compromised in tetracycline transactivator transgenic miceAnja Schmitt, Klaus Schulze-Osthoff, Stephan Hailfinger
Journal of Chromatography. A|May 2, 2026
In-depth phospholipid profiling of lymphoma cells by HPLC coupled with trapped ion mobility spectrometry and high-resolution tandem mass spectrometryDominik Wieland, Anja Schmitt, Stephan Hailfinger, et al.
Biomedicines|February 25, 2022
The Paracaspase MALT1 in CancerBeatriz Gomez Solsona, Anja Schmitt, Klaus Schulze-Osthoff, et al.
Virchows Archiv : an International Journal of Pathology|July 9, 2011
Hormonally defined pancreatic and duodenal neuroendocrine tumors differ in their transcription factor signatures: expression of ISL1, PDX1, NGN3, and CDX2Gratiana Hermann, Björn Konukiewitz, Anja Schmitt, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Blood Advances|June 25, 2026
Three generations, one target: BTK inhibitors in lymphomaAnja Schmitt, Stephan Hailfinger
Proceedings of the National Academy of Sciences of the United States of America|March 21, 2002
Inhibition of Xenopus oocyte meiotic maturation by catalytically inactive protein kinase AAnja Schmitt, Angel R Nebreda
Journal of Cell Science|June 5, 2002
Signalling pathways in oocyte meiotic maturationAnja Schmitt, Angel R Nebreda
Frontiers of Hormone Research|August 26, 2015
Pathology: Classification and ImmunoprofileAnnika Blank, Anja Schmitt, Aurel Perren
The FEBS Journal|December 31, 2015
The paracaspase MALT1 dampens NF-κB signalling by cleaving the LUBAC subunit HOIL-1Stephan Hailfinger, Anja Schmitt, Klaus Schulze-Osthoff
Therapeutische Umschau. Revue Therapeutique|October 2, 2010
[Pathology of malignant lymphomas--clarity instead of confusion]Esther Mueller-Garamvölgyi, Aurel Perren, Anja Schmitt
Cell Death and Differentiation|January 21, 2018
Correspondence: T cells are compromised in tetracycline transactivator transgenic miceAnja Schmitt, Klaus Schulze-Osthoff, Stephan Hailfinger
Journal of Chromatography. A|May 2, 2026
In-depth phospholipid profiling of lymphoma cells by HPLC coupled with trapped ion mobility spectrometry and high-resolution tandem mass spectrometryDominik Wieland, Anja Schmitt, Stephan Hailfinger, et al.
Biomedicines|February 25, 2022
The Paracaspase MALT1 in CancerBeatriz Gomez Solsona, Anja Schmitt, Klaus Schulze-Osthoff, et al.
Virchows Archiv : an International Journal of Pathology|July 9, 2011
Hormonally defined pancreatic and duodenal neuroendocrine tumors differ in their transcription factor signatures: expression of ISL1, PDX1, NGN3, and CDX2Gratiana Hermann, Björn Konukiewitz, Anja Schmitt, et al.
Pageof 5